Showing 1 - 4 results of 4 for search 'Guido Kobbe', query time: 0.01s Refine Results
  1. 1
    Nivolumab Induces Durable Remission in Relapsed/Refractory ALK‐Negative ALCL After Allogeneic Blood Stem Cell Transplantation—A Case Report and Literature Review

    Nivolumab Induces Durable Remission in Relapsed/Refractory ALK‐Negative ALCL After Allogeneic Blood Stem Cell Transplantation—A Case Report and Literature Review by Ben‐Niklas Baermann, Kathrin Nachtkamp, Paul Jäger, Paula Kessler, Emil Novruzov, Frederik L. Giesel, Helena Peters, Maximilian Seidl, Mark Uhlenbruch, Sascha Dietrich, Guido Kobbe

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapy

    The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoin... by Emil Novruzov, Helena A. Peters, Kai Jannusch, Guido Kobbe, Sascha Dietrich, Johannes C. Fischer, Jutta Rox, Gerald Antoch, Frederik L. Giesel, Christina Antke, Ben-Niklas Baermann, Eduards Mamlins

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients

    Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients by Paul Jäger, Benno Biermann, Nora Liebers, Felicitas Schulz, Ben‐Niklas Baermann, Sören Twarock, Stefanie Geyh, Kathrin Nachtkamp, Patrick Tressin, Annika Kasprzak, Felix Matkey, Titus Watrin, Malika El Yaouti, Ulrich Germing, Sascha Dietrich, Guido Kobbe

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients

    Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients by Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Oliver Kriege, Mareike Verbeek, Katrin Koch, Julia Marie Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Hänel, Charlotte Neuerburg, Vladan Vucinic, Christian-Friedrich Jehn, Maxi Wass, Michael Heuser, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Krüger, Ulrich Kaiser, Sebastian Scholl, Guido Kobbe, Paul Sebastian Jäger, Nael Alakel, Malte von Bonin, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Tim Sauer, Katharina S. Götze, Eva Wagner-Drouet, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Sara Flossdorf, Thomas Schroeder, Friedrich Stölzel

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: